# Columbian Quinoa (Chenopodium quinoa 'Titicaca')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/columbian-quinoa
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Chenopodium quinoa, Quinua, Quinua Real, Andean Rice, Inca Rice, Chisaya Mama, Pseudocereal, Keen-wah

## Overview

Columbian Quinoa (Chenopodium quinoa 'Titicaca') is a specific quinoa cultivar characterized by its high concentrations of 11S globulin (37%) and 2S albumin (35%), storage proteins that together provide a complete essential amino acid profile. Its notably low protease inhibitor activity distinguishes it from other quinoa varieties by reducing enzymatic interference during protein [digestion](/ingredients/condition/gut-health), potentially improving bioavailability.

## Health Benefits

• High-quality protein source containing 11S globulin (37%) and 2S albumin (35%) with complete amino acid profile (evidence quality: compositional analysis only)
• Low protease inhibitor activity suggesting enhanced digestibility compared to other quinoa varieties (evidence quality: in-vitro analysis)
• Rich mineral content at 2.83-2.88 g/100g dry matter (evidence quality: compositional analysis only)
• Potential [antioxidant activity](/ingredients/condition/antioxidant) linked to protein structure aromatic C-H bends (evidence quality: preliminary/theoretical)
• High protein solubility (69-70%) and emulsion stability supporting nutrient absorption (evidence quality: in-vitro analysis)

## Mechanism of Action

The 11S globulin (legumin-type) and 2S albumin fractions in Columbian Quinoa 'Titicaca' provide all essential amino acids, including lysine and methionine, which are rate-limiting in most plant proteins. Reduced levels of Bowman-Birk-type protease inhibitors mean serine proteases such as trypsin and chymotrypsin face less competitive inhibition in the gut lumen, allowing more efficient hydrolysis of dietary protein into absorbable peptides. This combination of favorable protein composition and diminished antinutritional interference supports higher net protein utilization compared to varieties with greater inhibitor activity.

## Clinical Summary

Current evidence for Columbian Quinoa 'Titicaca' is limited to compositional analyses and in-vitro digestibility assays; no controlled human clinical trials specific to this cultivar have been published as of the available data. In-vitro proteolysis studies indicate that the reduced protease inhibitor content correlates with measurably higher simulated gastrointestinal protein hydrolysis rates relative to higher-inhibitor quinoa cultivars, though exact quantified outcomes depend on assay conditions. Broader quinoa research in human populations (small trials, typically n=20–50) suggests quinoa protein is nutritionally comparable to casein in protein digestibility-corrected amino acid score (PDCAAS), but these findings cannot be directly extrapolated to 'Titicaca' without cultivar-specific trials. Overall, the evidence base is preliminary and mechanistic rather than clinical.

## Nutritional Profile

Protein: ~14-16g/100g dry weight, dominated by 11S globulin (chenopodin, ~37% of total protein) and 2S albumin (~35%), providing a complete essential amino acid profile including lysine (~5.1g/100g protein), methionine, and threonine — nutritionally superior to most plant proteins. Carbohydrates: ~60-65g/100g dry weight, primarily starch with low glycemic characteristics; dietary fiber ~7-10g/100g. Fat: ~5-7g/100g, with favorable fatty acid profile including linoleic acid (omega-6) and alpha-linolenic acid (omega-3). Total mineral content: 2.83-2.88g/100g dry matter — notably iron (~4-5mg/100g), calcium (~47-70mg/100g), magnesium (~197mg/100g), phosphorus (~383mg/100g), zinc (~3.1mg/100g), and potassium (~926mg/100g); bioavailability of minerals may be modestly reduced by phytates but low saponin content in 'Titicaca' variety mitigates anti-nutrient burden. Vitamins: B-vitamins present including folate (~78µg/100g), riboflavin (B2, ~0.32mg/100g), thiamine (B1, ~0.36mg/100g), and tocopherols (vitamin E, ~2.6mg/100g as alpha-tocopherol). Bioactive compounds: low protease inhibitor activity relative to other quinoa varieties enhances protein digestibility (in-vitro PDCAAS estimated >0.9); saponin content reduced in 'Titicaca' cultivar, improving palatability and reducing anti-nutritional interference. Polyphenols including quercetin and kaempferol present at ~48-49mg/100g combined. Betacyanins and betaxanthins present in minor amounts. Overall bioavailability assessment: high-protein digestibility due to reduced enzyme inhibitors; mineral bioavailability is moderate and benefits from washing/cooking to further reduce residual saponins and phytates.

## Dosage & Preparation

No clinically studied dosage ranges are available for Columbian Quinoa 'Titicaca' as no human trials have been conducted. Compositional data indicates typical serving sizes would provide starch content of 60-72% and protein content of 13-16% in whole seeds. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Columbian Quinoa 'Titicaca' is generally regarded as safe for most adults when consumed as a whole food or food-grade ingredient, consistent with the broad safety profile of quinoa. Saponins present on the seed coat can cause mild gastrointestinal irritation if the grain is not thoroughly rinsed before consumption, though their concentration in this cultivar has not been independently quantified. Individuals with known sensitivities to Chenopodiaceae family plants should exercise caution, and those with oxalate-related kidney stones should moderate intake given quinoa's moderate oxalate content. No specific drug interactions have been documented for this cultivar, but its high fiber content could theoretically slow absorption of orally administered medications if consumed simultaneously; pregnancy safety data specific to this cultivar are absent, though general quinoa consumption during pregnancy is not contraindicated.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specific to Chenopodium quinoa 'Titicaca' were identified in the current research. Available studies focus exclusively on physicochemical and compositional analyses of seed properties rather than health outcomes.

## Historical & Cultural Context

Quinoa has been cultivated by Indigenous Andean peoples including the Inca civilization for over 5,000 years as a staple food source for energy and nutrition. The 'Titicaca' variety specifically has no documented traditional medicinal uses, being valued primarily as a nutritious grain alternative.

## Synergistic Combinations

Other quinoa varieties, plant-based proteins, [digestive enzyme](/ingredients/condition/gut-health)s, mineral complexes, B-vitamins

## Frequently Asked Questions

### What makes Columbian Quinoa 'Titicaca' different from other quinoa varieties?

The 'Titicaca' cultivar is distinguished by its specific protein fraction profile—approximately 37% 11S globulin and 35% 2S albumin—and by its unusually low protease inhibitor activity compared to many other quinoa varieties. This combination means the protein is both compositionally complete (covering all essential amino acids) and less obstructed during enzymatic digestion, which may translate to higher practical protein availability from a given serving.

### How much protein does Columbian Quinoa 'Titicaca' contain per serving?

Exact per-serving protein content for the 'Titicaca' cultivar specifically has not been widely published in isolation, but quinoa grains in general contain approximately 14–16 g of protein per 100 g dry weight. Because 'Titicaca' has a favorable 11S globulin and 2S albumin ratio and reduced antinutritional factors, a greater proportion of that protein may be digested and absorbed compared to varieties with higher protease inhibitor content, though precise net protein values await human feeding studies.

### Does Columbian Quinoa 'Titicaca' have a complete amino acid profile?

Yes, compositional analysis confirms that the protein fractions of Columbian Quinoa 'Titicaca'—primarily 11S globulin and 2S albumin—collectively supply all nine essential amino acids, including lysine (often limiting in cereal grains) and sulfur-containing amino acids like methionine. This makes it one of the few plant sources providing a nutritionally complete protein, comparable in amino acid distribution to casein or soy protein.

### Is Columbian Quinoa 'Titicaca' easier to digest than regular quinoa?

In-vitro digestibility assays suggest that 'Titicaca' exhibits lower Bowman-Birk-type protease inhibitor activity than some other quinoa cultivars, which means trypsin and chymotrypsin in the digestive tract encounter less inhibition when breaking down its proteins. While this mechanistically supports improved digestibility, the practical magnitude of this advantage in living humans has not yet been quantified through controlled feeding studies, so the claim remains supported by in-vitro rather than clinical evidence.

### Can Columbian Quinoa 'Titicaca' be used as a protein supplement ingredient?

Its high-quality protein composition—complete essential amino acid profile, favorable 11S globulin and 2S albumin fractions, and low protease inhibitor activity—makes Columbian Quinoa 'Titicaca' a theoretically attractive ingredient for plant-based protein supplements or functional foods. However, no commercial supplement products specifically featuring this cultivar have been broadly documented in the scientific literature, and formulation factors such as saponin removal, processing temperature, and matrix effects would influence final protein quality in any finished product.

### Is Columbian Quinoa 'Titicaca' safe for people with gluten sensitivity or celiac disease?

Yes, Columbian Quinoa 'Titicaca' is naturally gluten-free, making it a safe choice for individuals with celiac disease or gluten sensitivity. As a pseudocereal rather than a true grain, it does not contain gluten proteins found in wheat, barley, or rye. However, cross-contamination may occur during processing, so look for products certified gluten-free if this is a concern.

### What is the mineral content of Columbian Quinoa 'Titicaca' compared to other plant-based protein sources?

Columbian Quinoa 'Titicaca' contains 2.83–2.88 g of minerals per 100g of dry matter, providing significant amounts of magnesium, manganese, phosphorus, and iron. This mineral density is notably higher than many other plant-based proteins like legumes and conventional grains on a per-gram basis. This makes it particularly valuable for those seeking mineral-rich whole food supplementation.

### Does the low protease inhibitor activity in Columbian Quinoa 'Titicaca' affect how it should be prepared?

The reduced protease inhibitor content in Columbian Quinoa 'Titicaca' suggests it may require less processing to maximize nutrient bioavailability compared to other quinoa varieties. While standard rinsing and cooking methods remain beneficial for removing saponins and optimizing taste, the lower anti-nutrient profile may allow for more flexible preparation methods. This makes it a convenient option for quick preparation in supplement formulations or ready-to-eat products.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*